Atlas Trials

Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Clinical trial NCT01402271 · COMPLETED

Trial details

NCT number
NCT01402271
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Start date
2012-07-01
Primary completion
2019-05-15
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.